Healthcare & Medical Devices Global On demand · 24-48h

Global Ophthalmic Scalpel Market Strategic Research Report

Global Ophthalmic Scalpel Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Ophthalmic Scalpel Market
$8342025
6.7%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Diamond Scalpel, Stainless Steel Scalpel, Others

By Application: Disposable, Reusable

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Alcon (US), MANI, INC. (JP), Corza Medical (US), BVI Medical (US), Bausch + Lomb (US), Feather Safety Razor (JP), Aurolab (IN), Lenstec (US), AdvinHealthcare (IN), Surgistar (US), Diamatrix (JP), Moria (FR), Sidapharm (GR), Eyebright Medical Technology (CN), Tianjin Century Healthcare Biomedical (CN), BHKY Medical (CN), Zhenxu Medical (CN)

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 131 pages
Market size 2025
$834
Million USD
Forecast CAGR
6.7%
2025-2032
Forecast 2032
$1313.2
Projected
Regiones
5
Asia Pacific · Latin America · MEA · Europe · North America

Vista general

Scope of the Report

The global Ophthalmic Scalpel market size is predicted to grow from US$ 834 million in 2025 to US$ 1,307 million in 2032; it is expected to grow at a CAGR of 6.7% from 2026 to 2032.

Ophthalmic scalpels are ultra-high-precision stainless steel instruments designed for delicate eye surgeries, such as cataract removal and corneal transplants. They feature exceptionally sharp blades to minimize tissue resistance and trauma. In 2025, global Ophthalmic Scalpel production reached approximately 155 million units, with an average global market price of around 5.5 US$/Unit. The production capacity of Ophthalmic Scalpel reaches 195 million units, and the industry's gross profit margin is approximately between 40% and 60%.

The market demand for ophthalmic scalpels continues to grow, primarily driven by multiple factors, including the increasing number of cataract and refractive error patients worldwide, the rising popularity of minimally invasive ophthalmic surgery, the advantages of disposable high-precision instruments in infection control and surgical efficiency, and the upgrading of products towards sharper, more stable, and safer products driven by advanced materials and precision manufacturing technologies. Simultaneously, the improvement of medical infrastructure in emerging markets and the commercialization of high-end ophthalmic treatment services have further expanded the clinical demand for high-quality ophthalmic scalpels.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Ophthalmic Scalpel market?

What factors are driving Ophthalmic Scalpel market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Ophthalmic Scalpel market opportunities vary by end market size?

How does Ophthalmic Scalpel break out by Type, by Application?

This report presents a comprehensive overview of the global Ophthalmic Scalpel market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Diamond Scalpel
  • Stainless Steel Scalpel
  • Others

Segment by Structure

  • Beveled Blade
  • Lancet Point
  • Round Tip
  • Diamond Knife

Segment by Application

  • Hospital
  • Clinic

Segment by Application

  • Disposable
  • Reusable

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Ophthalmic Scalpel market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Disposable, Reusable evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Ophthalmic Scalpel Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.7%
Regional growth momentum
Market share by segment
Key metrics
Base value
$834
2025
Forecast
$1313.2
2032
CAGR
6.7%
2025–2032
Regiones
5
global
Key companies
Alcon (US)MANIINC. (JP)Corza Medical (US)BVI Medical (US)Bausch + Lomb (US)Feather Safety Razor (JP)Aurolab (IN)
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Diamond ScalpelStainless Steel ScalpelOthers
By Application
DisposableReusable

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Diamond Scalpel
  • 3.1.3 Stainless Steel Scalpel
  • 3.1.4 Others
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Disposable
  • 4.1.3 Reusable
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Alcon (US)
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 MANI, INC. (JP)
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Corza Medical (US)
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 BVI Medical (US)
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Bausch + Lomb (US)
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Feather Safety Razor (JP)
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Aurolab (IN)
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Lenstec (US)
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 AdvinHealthcare (IN)
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Surgistar (US)
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Diamatrix (JP)
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Moria (FR)
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Sidapharm (GR)
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Eyebright Medical Technology (CN)
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Tianjin Century Healthcare Biomedical (CN)
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 BHKY Medical (CN)
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Zhenxu Medical (CN)
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Ophthalmic Scalpel market?
The global Ophthalmic Scalpel market is estimated at US$ 834 million in 2025 (base year) and is projected to reach US$ 1.31 billion by 2032.
What is the forecast CAGR for the Ophthalmic Scalpel market?
The market is expected to grow at a CAGR of 6.7% from 2026 to 2032, expanding from US$ 834 million in 2025 to US$ 1.31 billion in 2032, roughly 1.6 times its base-year value.
What is Ophthalmic Scalpel?
Ophthalmic scalpels are ultra-high-precision stainless steel instruments designed for delicate eye surgeries, such as cataract removal and corneal transplants. They feature exceptionally sharp blades to minimize tissue resistance and trauma. In 2025, global Ophthalmic Scalpel production reached approximately 155 million units, with an average global market price of around 5.5 US$/Unit.
What are the main segments of the Ophthalmic Scalpel market by type?
By type, the market is segmented into Diamond Scalpel, Stainless Steel Scalpel and Others.
Which applications drive demand in the Ophthalmic Scalpel market?
Key applications covered include Disposable and Reusable.
Who are the key players in the Ophthalmic Scalpel market?
Key players profiled include Alcon (US), MANI, INC. (JP), Corza Medical (US), BVI Medical (US), Bausch + Lomb (US), Feather Safety Razor (JP), Aurolab (IN) and Lenstec (US), among 17 companies covered in total.
Which regions and countries are covered for Ophthalmic Scalpel?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Ophthalmic Scalpel market?
What factors are driving Ophthalmic Scalpel market growth, globally and by region?
Who should buy the Ophthalmic Scalpel market report?
The report is intended for manufacturers and solution providers, distributors and end users in Disposable and Reusable, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Ophthalmic Scalpel market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from 3.500,00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.